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Objective: Chronic stress may be a risk factor for coronary heart disease and is associated with dysregulation of the hypothalamic–
pituitary–adrenal (HPA) axis. We tested the hypotheses that two markers of HPA axis dysregulation, elevated average level (area under
the curve, adjusted for time awake) and diurnal decline of salivary cortisol, were associated with presence of coronary calcification (CaC).
Method: Seven hundred eighteen black and white middle-aged adults enrolled in an ancillary study of Coronary Artery Risk
Development in Young Adults provided six salivary cortisol samples throughout one full day and had measurements of CaC. Results:
The prevalence of any calcification was low, 8.1% in the participants of the ancillary study, with white men having the highest proportion.
Average cortisol did not differentiate groups, means  2.15 and 2.08. Those with any CaC declined approximately 6% per hour in cortisol
over the course of the day, whereas those with no CaC declined more than 8% per hour (p  .003). Those persons with slope scores in
the flattest quartile had a greater likelihood of any CaC than did those in the remaining quartiles adjusted for sex–race group, age, smoking,
treatment for diabetes, systolic blood pressure, logged triglycerides, average cortisol, and educational attainment (odds ratio  2.58; 95%
confidence interval  1.26–5.30). Conclusions: Our results are consistent with the hypothesis that HPA axis dysregulation may affect
risk for atherosclerosis. Key words: coronary calcification, neuroendocrine, stress, cortisol.
CHD  coronary heart disease; HPA  hypothalamic–pituitary–
adrenal; CARDIA  Coronary Artery Risk Development in Young
Adults; CaC  coronary artery calcification; BMI  body mass
index; LDL-C  low-density lipoprotein cholesterol; HU 
Hounsfield unit; BP  blood pressure; HDL  high-density lipopro-
tein; AUC  area under the curve; SBP  systolic blood pressure.
INTRODUCTION
Cumulative exposure to chronic stressors may be a risk factorfor coronary heart disease (CHD (1)). Individuals who are
exposed to high levels of demands and low levels of control at
work, to distressing marriages, and to low social support are more
likely to have incident CHD than their less stressed counterparts
(2–4). Dysregulation of the hypothalamic–pituitary–adrenal
(HPA) axis is one of the pathways through which chronic stress
may affect CHD risk. In healthy individuals, cortisol has a
distinct diurnal pattern with the peak cortisol occurring in the
early morning, declining throughout the day, and reaching a nadir
around 2 or 3 AM (5). Cortisol also exhibits sizable, short-term
increases during the first hour after awakening and in response to
a lunch meal or a threat-provoking stressor. Aging is associated
with increased mean 24-hour plasma cortisol, but the diurnal
variation is preserved (5). Dysregulation can take the form of
altered overall levels of cortisol or a smaller decline in cortisol
throughout the day and evening, i.e., flatter slope.
The literature clearly supports that chronic stress in both
animal and human studies alters the ability of the HPA axis to
recover from challenges (6). Elevated cortisol levels are as-
sociated with depressive symptoms (7), anxiety (8), caregiver
stress (9), unemployment (10), and overall negative affect
(11). Elevated evening cortisol, resulting from a smaller cor-
tisol decline throughout the day, is associated with unhappy
marriages (12), low positive affect (men only (11)) and de-
pressive symptoms, low network diversity, support, feelings
of control, and low socioeconomic status (13). No epidemio-
logic studies have tested the association between cortisol level
and pattern and risk for CHD, although a higher level of
morning cortisol has been observed among men with moder-
ate to severe coronary atherosclerosis than those with no
detectable disease (14). In the ongoing epidemiologic study of
young and middle-aged adults called the Coronary Artery
Risk Development in Young Adults (CARDIA (15)), we
tested the hypothesis that coronary calcification (CaC) is as-
sociated with average awake cortisol level and diurnal pattern,
i.e., the average rate of decline throughout the day.
METHODS
Participants
CARDIA is an ongoing prospective, multicenter study of the natural
history of cardiovascular risk development starting in young adulthood.
Participants were initially recruited in 1985 to 1986 to achieve a balance at
each of four sites by race (black, white), sex, and education (high school
degree or less vs. more than a high school degree). Detailed description of the
original sampling procedure is available elsewhere (15). Participants were
examined at study entry and years 2, 5, 7, 10, and 15 with the reexamination
rate among surviving cohort members at year 15 of 73.5%. Comparisons of
CARDIA participants in the year 15 examination with nonparticipants
showed that nonparticipants were more likely to be black, younger, less
educated, and smokers (16). Site institutional review committee approval and
informed consent were obtained for each examination. The CARDIA Publi-
cations Committee approved this article.
At the year 15 examination conducted in 2000 to 2001, participants at the
Oakland and Chicago sites living within 50 miles of the clinic were invited to
participate in an ancillary study of socioeconomic status, which included
assessment of salivary cortisol. Informed consent was obtained separately for
participation in the ancillary study. Of the 1336 participants who were eligible
for the ancillary study, 836 (62.6%) agreed to participate and 808 returned
salivettes containing saliva. Excluded from analysis were two because of
inadequate data on the times that samples were collected, 25 because they
awoke after 11 AM and had a distinctly different cortisol pattern from the
remainder of the sample, one who reported having had a heart attack, and 62
who did not have CaC measures. The final sample was 151 and 235 black men
and women, respectively, and 154 and 178 white men and women, respec-
tively. Among those who participated in the CaC protocol at the two sites,
participants in the ancillary study had higher body mass index (BMI), less
education, and were more likely to be black compared with nonparticipants in
the ancillary study at the two sites; they were similar in age, blood pressure,
low-density lipoprotein cholesterol (LDL-C), and percentage of women, cur-
rent smokers, or those having any calcification.
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Coronary Calcification
Coronary calcification was measured by using an Imatron C-150 electron
beam scanner. A committee of cardiologists, radiologists, and a physicist
developed a scanning protocol to standardize scan acquisition, which included
two 2.5- to 3-mm thick electrocardiogram-gated scans completed within 100
to 520 ms on each participant using a hydroxyapatite phantom to allow
standardization of image brightness. With the help of specialized image
processing software, trained readers identified the presence of CaC in each
scan (17). A total CaC score was calculated for each scan by multiplying the
area of the focus by a coefficient ranging from 1 to 4 based on the peak
density in the focus (1  130–200 Hounsfield units [HU], 2  201–300 HU,
3  301–400 HU, and 4  401 HU) according to the method described by
Agatston (18). All readers were blind to participant characteristics. Both
between- and within-reader reproducibility were high (17).
Other Relevant Measures
Standardized questionnaires were used to assess age, race, sex, treatment
for diabetes, and years of education. At each examination, three seated blood
pressure (BP) measurements at 1-minute intervals were taken on the right arm
using a Hawksley random zero sphygmomanometer (WA Baum Co., Co-
paigue, NY) after a 5-minute rest. Systolic BP and diastolic BP were recorded
as phase I and phase V Korotkoff sounds, and the latter two measures were
averaged. BMI was calculated as measured weight (in kilograms) divided by
height squared (in meters). Smoking status was categorized as currently
smoking at least five cigarettes per week, yes/no. A fasting blood draw was
conducted and total cholesterol, triglycerides, and high-density lipoprotein
(HDL) cholesterol were measured (19) with LDL-C calculated by the Friede-
wald equation.
Cortisol Protocol and Data Reduction
Cortisol was measured in saliva as opposed to plasma because of the
epidemiologic and ambulatory nature of the study. Salivary “free” cortisol
levels track closely with plasma levels, correlations ranging from 0.70 to 0.90
(20) showing a 1- to 2-minute lag, and have been previously used to monitor
cortisol activity in both ambulatory and laboratory challenge paradigms
(21–22). Participants were given materials and instructed regarding the col-
lection of the saliva samples at the conclusion of their year 15 follow-up
CARDIA clinic visit. Samples were collected from participants on a single
weekday, in most cases the Monday after a Friday or Saturday clinic visit.
They provided six saliva samples over the course of the day: at awakening
(“when your eyes open and you are ready to get up”), 45 minutes, 2.5 hours,
8 hours, and 12 hours after awakening, and at bedtime (“right before getting
into bed”). Participants were instructed to record the time they woke up in a
log and were provided with alarm watches (preset to their regular wakeup
time) to remind them to collect samples; they were also given a form that
allowed them to easily recalculate the desired sample times if they woke up
at a different time than anticipated.
To provide a saliva sample, participants placed a roll of cotton in their
mouths, chewed on it for approximately 30 seconds or until it became
saturated, and placed it in a tube called a salivette (Sarstedt, Rommelsdorft,
Germany). They then filled in the time of the sample on the tube label. The
investigators collected all six salivettes the next morning. Salivettes were
refrigerated at each site until they were assayed. Cortisol level was determined
by time-resolved immunoassay with fluorometric end point detection (23).
Nine samples with levels below the minimum detectable level (0.7 nmol/L)
for this assay were assigned values of 0.5 nmol/L. Intra- and interassay
variabilities were each less than 12%.
Not every cortisol sample was taken precisely at the intended time. For
each of the six targeted times, a window relative to time since awakening was
established for considering the sample collected at the appropriate time. This
window was narrowest for the morning sample as a result of the typical
pattern of a rapid increase in cortisol during the first 30 to 60 minutes after
awakening (the “morning rise”) followed by a more gradual, but steady,
decrease during the rest of the day. The targeted times and windows were as
follows: 15 minutes for wakeup, 15 to 90 minutes for 45 minutes, 2
to 3.5 hours for 2.5 hours, 7 to 9 hours for 8 hours, 11 to 13
hours for 12 hours, and 12 to 20 hours for bedtime. The sixth sample
was not targeted to a specific time. The window for each target time was
determined from preliminary analyses documenting the interval over which
there was no systematic tendency for cortisol levels to differ from those
obtained within 5 minutes of the target time. A sample provided outside the
acceptable window was excluded from analyses of samples for that targeted
time.
Analyses reported subsequently were performed separately on each of the
six targeted cortisol samples after natural logarithmic transformation to re-
duce the positive skewness. However, the main focus was on two summary
measures of cortisol: area under the curve (AUC) and slope. AUC, a time-
adjusted measure of total cortisol exposure while awake, was calculated as the
AUC defined by the plot of log-transformed cortisol values against collection
times multiplied by 16 hours and divided by the duration, in hours, between
the first and last sample. The AUC measure was computed only for those who
had data for the first and/or second sample and a minimum of 12 hours
between their first and last samples; 18 were excluded from AUC analyses.
The slope was calculated for those who had at least the first or second sample
and the fifth or sixth sample; 13 participants were therefore excluded from the
slope analyses; six participants had slopes calculated based on the second
cortisol sample rather than the first. The slope was estimated by fitting a linear
regression line separately for each participant that predicted the log-trans-
formed cortisol values from time (hours) since awakening. To minimize the
impact of the morning rise on the estimation of slopes, the second saliva
sample was excluded from the calculation of slopes for all but the six
otherwise eligible participants who did not have a first cortisol sample
collected within 60 minutes of awakening. Because the AUC and slope were
based on real time, it was not necessary to exclude available data outside the
targeted windows.
Statistical Analyses
Data are reported as means and standard deviations or proportions, and
preliminary analyses by t tests were conducted on differences between those
with and without any calcification. Because only a small minority of partic-
ipants had any measurable calcification, we used logistic regression analysis
to predict presence/absence of measurable calcification. (Preliminary Tobit
conditional regression analysis, which applies linear regression to continuous
data [CaC scores] did not reveal a graded relationship with extent of calcifi-
cation.) Initial models adjusted for race–gender group, treatment for diabetes,
and age; subsequent models also adjusted for risk factors that were associated
with CaC (p  .10): smoking status, systolic blood pressure (SBP), logged
triglycerides, and education attainment. To test whether the relationship
between cortisol’s diurnal pattern and CaC or AUC was linear or nonlinear,
we collapsed the distribution of diurnal slopes into quartiles (using cut points
of 0.11758, 0.8775, and 0.049955) and examined their relationship to
CaC. To examine if the effect of slope was independent of the level of
cortisol, we investigated whether the results changed when also adjusting for
AUC.
RESULTS
On average, participants were 40 years old with almost
20% smokers (Table 1). Mean BMI of the total and four
sex–race subgroups was within the overweight range, except
for black women whose mean was in the obese range. The
number of participants with measurable calcification was low
in this relatively young sample. Men were more likely to have
measurable coronary calcification than women with white
men having the highest and white women the lowest preva-
lence. Participants with CaC did not differ in time since
awakening at sample collections from those with no CaC (all
p  .15).
Although participants with calcification did not differ sig-
nificantly from those without calcification on any of the six
individual cortisol samples, there was a tendency for the last
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three samples to be higher in those with calcification (all p 
.20). As a result, those with calcification had flatter diurnal
slopes of cortisol than did those without calcification, al-
though there were no differences by group in cortisol AUC
(Table 2). The mean slope of 0.061 for the group with any
calcification means that, on average, (untransformed) cortisol
decreased at a rate of approximately 6% per hour over the
course of the day, whereas the mean slope of 0.084 means
that on average cortisol decreased at a rate of more than 8%
per hour over the course of the day.
The association between cortisol slopes (continuous) and
having any calcification was significant in the logistic regres-
sion model adjusting for sex–race group, treatment for diabe-
tes, and age (Table 3, row 1). The analysis based on the four
quartiles of the cortisol slope showed that compared with the
quartile with the steepest cortisol slopes, the quartile with the
flattest slopes was approximately 31⁄3 times more likely to
have any calcification, whereas there were no differences
among the remaining quartiles (all p  .70) (controlling for
sex–race group, treatment for diabetes, and age; see Fig. 1).
Compared with the three other quartiles combined, those in
the quartile with the flattest slopes were markedly more likely
to have any calcification. A similar analysis using AUC as the
predictor variable did not show a nonlinear association with
CaC.
These associations remained statistically significant when
adjusted for race–gender groups, age, current smoking, SBP,
triglycerides, and educational attainment (Table 3, row 2).
Additionally controlling for AUC, a time-weighted estimate of
average cortisol during the day did not substantially alter the
relationship.
The Hosmer and Lemeshow goodness-of-fit statistic was
used to estimate the validity of the logistic regression models
presented in Table 3. For none of these models was there
evidence of a poor fit; the significance levels for this test
ranged from p  .09 to .90 (mean p  .38), in which a
nonsignificant result indicates an adequate or good fit.
DISCUSSION
The present article evaluated whether markers of HPA
function, i.e., average cortisol or diurnal pattern throughout
the day, were related to presence of coronary calcification in
young and middle-aged black and European American men
and women. Results showed that the flatter the cortisol slopes
throughout the day, the greater the likelihood of any coronary
calcification with the suggestion that the flatter slopes were
the result of elevated afternoon and evening levels as opposed
to lower morning levels. Further inspection of the data showed
that the relationship was nonlinear. That is, the flattest quartile
of cortisol slopes was associated with the presence of calcifi-
cation. These associations remained statistically significant in
models adjusting for sex–race group, age, treatment for dia-
betes, cigarette smoking, SBP, triglycerides, educational at-
tainment, and average cortisol levels measured across the day.
To our knowledge, this is the first epidemiologic study to
show that the cortisol pattern is related to risk for coronary
atherosclerosis.
To date, cortisol (and dysregulated HPA axis activity more
generally) has not been the focus of investigation as a poten-
tial contributor to coronary atherosclerosis. The plausibility of
a relationship between cortisol patterns and atherosclerosis is
in accord with a number of recent findings. Cortisol abnor-
TABLE 1. Sample Characteristics for Participants in the CARDIA Ancillary Study With Coronary Artery Calcification Measures, 2000 to 2001
Black Men Black Women White Men White Women Total
Variable (n  151) (n  235) (n  154) (n  178) (n  718)
Mean age, years (SD) 39.5 (3.6) 39.9 (3.9) 40.1 (3.5) 40.9 (3.3) 40.1 (3.6)
Mean body mass index, kg/m2 (SD) 29.6 (6.2) 32.3 (8.1) 27.5 (4.5) 26.4 (6.9) 29.2 (7.2)
Mean education, years (SD) 14.1 (2.1) 14.1 (2.2) 15.6 (2.6) 16.0 (2.3) 14.9 (2.4)
Mean systolic blood pressure, mm Hg (SD) 117.4 (13.7) 117.0 (15.4) 112.3 (11.0) 107.1 (13.4) 113.6 (14.3)
Mean high-density lipoprotein cholesterol, mg/dL (SD) 47.1 (13.4) 53.3 (12.8) 43.1 (11.1) 56.4 (13.7) 50.5 (13.8)
Mean low-density lipoprotein cholesterol, mg/dL (SD) 118.1 (34.0) 110.7 (30.9) 123.7 (34.5) 104.3 (26.1) 113.4 (32.0)
Mean triglycerides, mg/dL (SD) 106.3 (76.3) 83.9 (44.8) 153.6 (229.8) 93.8 (55.7) 106.3 (121.5)
Percent current smoker 27.2 25.2 11.0 11.8 19.2
Percent being treated for diabetes 2.6 3.8 1.9 0 2.2
Percent any coronary artery calcification 11.3 6.0 14.3 2.8 8.1
SD, standard deviation.
TABLE 2. Mean (standard deviation) of Logged Salivary Cortisol





(N  58) (N  660)
Awakening 2.71 (0.71) 2.81 (0.60) .23
3/4 hour 3.04 (0.61) 3.11 (0.55) .38
2.5 hr 2.51 (0.55) 2.54 (0.59) .70
8 hr 2.25 (0.55) 2.11 (0.66) .11
12 hr 1.76 (0.78) 1.59 (0.73) .12
Bedtime
(mean  16.8 hr)
1.67 (0.93) 1.51 (0.90) .19
Area under curve (per
16 hr)
2.15 (0.47) 2.08 (0.49) .30
Slope (change per
hour)
0.061 (0.064) 0.084 (0.054) .003
a Calculated with t test.
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malities are associated with increased abdominal obesity
(24,25). Pharmacologic inhibition of cortisol production pre-
vents mental stress-induced endothelial function and barore-
flex impairment, suggesting that cortisol may facilitate these
phenomena (26). Growing evidence links dysregulation of the
HPA axis with inflammatory processes (27), which then con-
tribute to the pathogenesis of atherosclerosis (28). Finally,
and most specific to calcification, animal data suggest that
vascular lesions may be less affected by the antiprolifera-
tive/antifibrotic effects of cortisol during chronic stress,
leading to excessive wound repair processes and calcifica-
tion (29).
Several features of this study are noteworthy. First, the sample
was small, relatively young, and very few had coronary calcifi-
cation. Thus, the findings should be considered preliminary.
Furthermore, the extent to which abnormal cortisol rhythms may
be related to calcification in older populations with significant
comorbidity and higher levels of calcification is unknown. Sec-
ond, the study was cross-sectional in design. Although it is
unlikely that coronary calcification alters HPA regulation, it is
possible that there is a third correlated factor accounting for both.
Indeed, we had reasoned that HPA dysregulation in response to
stress would increase the risk for calcification. However, in the
present sample, a flatter slope was not associated with number of
chronic problems, although it was associated with greater de-
pressive symptoms and lower emotional support and network
diversity (13). Third, we did not expect average cortisol level
summarized throughout the day to be unrelated to calcification.
However, it should be noted that average cortisol was related to
different and fewer psychosocial factors than was the slope in the
same sample (13). Furthermore, some stress-related diseases,
e.g., posttraumatic stress disorder, are associated with lower
cortisol levels, and some theorists believe that either hyperre-
sponsiveness or hyporesponsiveness of the HPA axis is deleteri-
ous (30). This notion is in keeping with the concept of allostatic
load in which both excessive responding or the failure to mount
an adequate response is considered to be health-damaging con-
sequences of stress (6). Finally, the methods of salivary cortisol
collection are demanding in ambulatory populations. Our data
would suggest that compliance with the timing of collection,
especially in the evening hours, is very important for hypothesis
testing.
In summary, we tested the hypothesis that cortisol level and
diurnal patterns are related to the risk of any coronary calci-
fication in a multiethnic sample. We found that a relatively flat
diurnal pattern is associated with the risk of coronary calcifi-
cation. These associations are independent of sociodemo-
graphic factors and established cardiovascular risk factors.
Abnormal cortisol patterns may play a role in understanding
why psychosocial factors are linked to risk for coronary dis-
ease. This is the first epidemiologic report of cortisol patterns
being related to coronary atherosclerosis.
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Figure 1. Probability of detectable coronary artery calcification by quartiles
of diurnal slope of salivary cortisol adjusted for sex, race, treatment for
diabetes, and age. p values refer to tests for whether the quartile group differs
from the reference group.
TABLE 3. Odds Ratio (95% confidence intervals) and p Values From Logistic Regression Models Testing the Relationship Between Diurnal
Salivary Cortisol Slope and Presence/Absence of Any Coronary Calcification
Covariates
Continuous Slope
Quartiles of Slope: Flattest
vs. Steepest Quartile
Flattest Slope Quartile vs.
All Other Quartiles
Odds Ratio p Odds Ratio p Odds Ratio p
Age, sex–race groups, and treatment
for diabetes
2.54 (1.42–4.53) 0.002 3.36 (1.48–7.61) 0.004 3.12 (1.71–5.70) 0.0002
Above covariates and systolic blood
pressure, current smoking status,
(log) triglycerides, educational
attainment
1.70 (0.91–3.17) 0.10 1.95 (0.81–4.67) 0.13 2.05 (1.06–3.97) 0.03
Above covariates and area under the
curve cortisol
2.13 (1.06–4.29) 0.03 2.59 (0.99–6.73) 0.05 2.58 (1.26–5.30) 0.01
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